NCT01318408 - Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Epilepsy

Interventions

DRUG

Levetiracetam

Titration of Keppra will start at 250 mg by mouth twice daily for three days. Then 500 mg by mouth twice daily for three days. Then 750 mg by mouth twice daily for the duration of the study, or for as long as treatment is necessary. This titration schedule is subject to change based on subject's tolerability.

Trial Locations (1)

19102

Drexel University College of Medicine, Dept of Neurology, Philadelphia